APACHE II Score Calculator: Understanding Critical Illness Severity

APACHE II Score Calculator

The Acute Physiology and Chronic Health Evaluation II (APACHE II) score is a severity-of-disease classification system widely used in intensive care units (ICUs) to estimate the risk of hospital mortality for critically ill patients. Enter the patient's physiological data, age, and chronic health status below to calculate the APACHE II score.

Acute Physiology Score (APS)

Age Score

Chronic Health Score

What is the APACHE II Score?

The APACHE II (Acute Physiology and Chronic Health Evaluation II) score is a widely recognized and utilized severity-of-disease classification system in the medical field, particularly within intensive care units (ICUs). Developed in 1985, its primary purpose is to quantify the severity of illness for critically ill patients, providing a standardized method to assess patient condition and predict hospital mortality risk.

It's an aggregate score derived from three main components: acute physiological derangement, age, and chronic health status. The score helps clinicians, researchers, and healthcare administrators to:

  • Compare outcomes between different ICUs or patient groups.
  • Evaluate the effectiveness of new therapies or interventions.
  • Allocate resources more efficiently.
  • Stratify patients for clinical trials.

Components of the APACHE II Score

The total APACHE II score is a sum of points from three distinct categories:

1. Acute Physiology Score (APS)

This is the largest component, contributing up to 60 points. It's calculated based on the worst values of 12 routine physiological measurements recorded during the first 24 hours of ICU admission. These variables reflect the acute severity of the patient's condition:

  • Temperature
  • Mean Arterial Pressure (MAP)
  • Heart Rate
  • Respiratory Rate
  • Oxygenation (PaO2 or AaDO2, depending on FiO2)
  • Arterial pH
  • Sodium
  • Potassium
  • Creatinine (doubled for acute renal failure)
  • Hematocrit
  • White Blood Cell Count (WBC)
  • Glasgow Coma Scale (GCS) (The score is 15 minus the actual GCS)

Each variable is assigned a score from 0 to 4 points based on its deviation from the normal range. Greater deviation results in a higher score.

2. Age Score

Points are added based on the patient's age, reflecting the increased risk associated with older age in critical illness:

  • Age ≤ 44 years: 0 points
  • Age 45-54 years: 2 points
  • Age 55-64 years: 3 points
  • Age 65-74 years: 5 points
  • Age ≥ 75 years: 6 points

3. Chronic Health Score

This component accounts for pre-existing severe organ system insufficiency or immunocompromised status, which can significantly impact patient outcomes. Points are assigned as follows:

  • For non-operative or emergency post-operative patients: 5 points if the patient has a history of severe organ system insufficiency or is immunocompromised.
  • For elective post-operative patients: 2 points if the patient has a history of severe organ system insufficiency or is immunocompromised.
  • 0 points if none of these conditions are present.

Examples of severe organ insufficiency include cirrhosis, chronic heart failure (NYHA Class IV), chronic respiratory disease requiring mechanical ventilation, chronic renal dialysis, or a history of transplant.

How is the APACHE II Score Calculated?

The calculation involves gathering the worst physiological values within the first 24 hours of ICU admission. Each value is then translated into a score using a standardized table. These individual scores are summed to get the APS. The APS is then added to the age score and the chronic health score to yield the final APACHE II score.

For instance, if a patient has a temperature of 41.5°C, a heart rate of 190 bpm, and is 80 years old with chronic renal failure admitted for an emergency, they would accumulate significant points from each category.

Interpreting the APACHE II Score

The total APACHE II score can range from 0 to 71. Generally, a higher APACHE II score indicates a greater severity of illness and, consequently, a higher predicted risk of hospital mortality. It's important to remember that:

  • The APACHE II score is a statistical tool for predicting mortality risk in groups of patients, not a precise predictor for individual patient outcomes.
  • It provides a probability of death, not a certainty. Many patients with high scores survive, and some with low scores may not.

Limitations and Considerations

While invaluable, the APACHE II score has certain limitations:

  • Not for Individual Prognostication: It should not be used in isolation to make treatment decisions for an individual patient. Clinical judgment remains paramount.
  • Data Collection: Accurate data collection of the worst physiological values within the first 24 hours can be challenging.
  • Specific Diagnoses: It does not account for specific diagnoses, which can significantly influence prognosis.
  • Temporal Relevance: Developed in the 1980s, it may not fully reflect advancements in critical care medicine and patient management.
  • Lack of Dynamic Assessment: It's a static score based on initial presentation, not designed for continuous, dynamic assessment of patient changes over time.

Evolution and Alternatives

Due to these limitations and the evolution of critical care, newer scoring systems have been developed:

  • APACHE III and APACHE IV: More complex versions of APACHE, incorporating more variables and refined algorithms.
  • SAPS II and SAPS III: Simplified Acute Physiology Score, also used for severity assessment.
  • SOFA (Sequential Organ Failure Assessment) Score: Used to track organ dysfunction or failure over time, particularly useful for sepsis.

These newer systems often offer improved predictive accuracy and adaptability to modern ICU environments.

Conclusion

The APACHE II score remains a fundamental tool in critical care for benchmarking, research, and resource management. By providing a standardized measure of illness severity, it contributes significantly to our understanding and improvement of care for critically ill patients. However, its application requires careful consideration of its strengths and limitations, always complementing it with expert clinical judgment.